Lexaria Bioscience LEXX
NASDAQ LEXX
$3.09 -0.04 (-1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Other financing activities (2020 - 2021)

Updated

Lexaria Bioscience's Other financing activities was -$1.24 million in fiscal Q1 2022 (quarter ended Nov 30, 2021), compared with -$768,408 a year earlier.

Analysis

Lexaria Bioscience (LEXX) Other financing activities (2020 - 2021) Analysis & Trends

For FY2019 (ended Aug 31, 2019), Other financing activities at Lexaria Bioscience came in at $1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lexaria Bioscience 3.26 Mn -12.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2021 -1.24 Mn
Nov 30, 2020 -768,408.00
API Access

Lexaria Bioscience Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LEXX&period=max&api_key=YOUR_API_KEY